Evotec Non Current Liabilities Total vs Common Stock Analysis
EVO Stock | USD 4.68 0.16 3.54% |
Evotec SE financial indicator trend analysis is much more than just examining Evotec SE ADR latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Evotec SE ADR is a good investment. Please check the relationship between Evotec SE Non Current Liabilities Total and its Common Stock accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
Non Current Liabilities Total vs Common Stock
Non Current Liabilities Total vs Common Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Evotec SE ADR Non Current Liabilities Total account and Common Stock. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Evotec SE's Non Current Liabilities Total and Common Stock is 0.55. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Common Stock in the same time period over historical financial statements of Evotec SE ADR, assuming nothing else is changed. The correlation between historical values of Evotec SE's Non Current Liabilities Total and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Evotec SE ADR are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Non Current Liabilities Total i.e., Evotec SE's Non Current Liabilities Total and Common Stock go up and down completely randomly.
Correlation Coefficient | 0.55 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Non Current Liabilities Total
Common Stock
Most indicators from Evotec SE's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Evotec SE ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. At this time, Evotec SE's Selling General Administrative is very stable compared to the past year. As of the 2nd of June 2024, Sales General And Administrative To Revenue is likely to grow to 0.26, while Tax Provision is likely to drop about 3.2 M.
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 618.0M | 751.4M | 781.4M | 820.5M | Depreciation And Amortization | 67.6M | 81.7M | 99.9M | 104.9M |
Evotec SE fundamental ratios Correlations
Click cells to compare fundamentals
Evotec SE Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Evotec SE fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.2B | 1.5B | 2.2B | 2.3B | 2.3B | 2.4B | |
Total Stockholder Equity | 477.0M | 722.8M | 1.4B | 1.2B | 1.1B | 1.2B | |
Common Stock Shares Outstanding | 151.5M | 154.9M | 167.1M | 176.7M | 176.9M | 188.4M | |
Liabilities And Stockholders Equity | 1.2B | 1.5B | 2.2B | 2.3B | 2.3B | 2.4B | |
Other Stockholder Equity | 786.9M | 1.0B | 1.4B | 1.4B | 1.4B | 733.8M | |
Other Assets | 58.0M | 62.3M | 79.3M | 1.0 | 1.15 | 1.09 | |
Short Long Term Debt Total | 463.1M | 492.0M | 512.9M | 506.7M | 626.2M | 657.5M | |
Other Current Liab | 53.5M | 65.3M | 74.5M | 87.4M | 73.3M | 77.0M | |
Total Current Liabilities | 179.0M | 208.5M | 324.5M | 337.7M | 464.6M | 487.8M | |
Property Plant And Equipment Net | 239.2M | 337.3M | 484.6M | 650.2M | 806.6M | 846.9M | |
Net Debt | 186.1M | 69.8M | (186.4M) | 91.5M | 115.3M | 121.1M | |
Retained Earnings | (441.2M) | (434.2M) | (216.4M) | (392.4M) | (476.3M) | (500.1M) | |
Accounts Payable | 31.3M | 42.5M | 72.6M | 97.3M | 134.3M | 141.0M | |
Cash | 277.0M | 422.2M | 699.3M | 415.2M | 510.9M | 536.5M | |
Non Current Assets Total | 711.4M | 804.1M | 1.1B | 1.2B | 1.4B | 1.5B | |
Non Currrent Assets Other | 23.7M | 37.4M | 56.8M | 74.1M | 95.2M | 100.0M | |
Cash And Short Term Investments | 321.7M | 492.2M | 858.5M | 730.0M | 604.1M | 634.3M | |
Short Term Investments | 44.6M | 70.1M | 159.2M | 314.8M | 93.2M | 74.6M | |
Non Current Liabilities Total | 524.9M | 531.6M | 533.0M | 732.4M | 714.6M | 750.3M | |
Other Current Assets | 3.8M | 6.5M | 20.7M | 40.2M | 64.1M | 67.3M | |
Total Liab | 703.9M | 740.0M | 857.5M | 1.1B | 1.2B | 1.2B | |
Total Current Assets | 469.5M | 658.8M | 1.1B | 1.1B | 903.2M | 948.3M | |
Short Term Debt | 20.7M | 30.0M | 50.6M | 16.4M | 149.1M | 156.5M | |
Common Stock | 150.9M | 163.9M | 176.6M | 177.0M | 177.2M | 128.1M | |
Current Deferred Revenue | 73.4M | 70.6M | 126.8M | 136.7M | 107.9M | 113.2M | |
Net Receivables | 124.1M | 136.9M | 176.8M | 256.7M | 204.1M | 214.3M | |
Inventory | 10.7M | 13.6M | 25.8M | 29.8M | 30.9M | 32.4M | |
Good Will | 255.9M | 247.4M | 257.6M | 274.8M | 275.6M | 289.4M | |
Intangible Assets | 117.0M | 98.0M | 30.9M | 23.8M | 15.5M | 14.7M | |
Accumulated Other Comprehensive Income | (19.6M) | (37.5M) | (12.6M) | (37.4M) | (30.6M) | (32.2M) | |
Other Liab | 93.2M | 82.6M | 69.6M | 70.7M | 63.6M | 61.8M | |
Net Tangible Assets | 79.0M | 102.9M | 375.9M | 1.1B | 1.3B | 1.3B | |
Long Term Debt | 324.9M | 331.0M | 326.3M | 328.3M | 377.5M | 254.0M | |
Capital Lease Obligations | 131.9M | 145.6M | 150.4M | 176.8M | 203.3M | 112.1M | |
Net Invested Capital | 808.3M | 1.1B | 1.7B | 1.5B | 1.1B | 1.1B | |
Short Long Term Debt | 6.3M | 15.4M | 36.1M | 1.6M | 1.4M | 1.3M | |
Net Working Capital | 290.6M | 450.4M | 776.4M | 736.0M | 438.6M | 421.1M | |
Property Plant Equipment | 89.3M | 238.0M | 335.7M | 484.6M | 557.3M | 585.2M | |
Long Term Investments | 41.3M | 59.0M | 287.0M | 150.3M | 142.1M | 129.9M | |
Capital Stock | 150.9M | 163.9M | 176.6M | 177.0M | 177.2M | 182.3M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Evotec Stock analysis
When running Evotec SE's price analysis, check to measure Evotec SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evotec SE is operating at the current time. Most of Evotec SE's value examination focuses on studying past and present price action to predict the probability of Evotec SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evotec SE's price. Additionally, you may evaluate how the addition of Evotec SE to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Evotec SE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evotec SE. If investors know Evotec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evotec SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.28) | Revenue Per Share 2.194 | Quarterly Revenue Growth (0.02) | Return On Assets 0.0003 | Return On Equity (0.08) |
The market value of Evotec SE ADR is measured differently than its book value, which is the value of Evotec that is recorded on the company's balance sheet. Investors also form their own opinion of Evotec SE's value that differs from its market value or its book value, called intrinsic value, which is Evotec SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evotec SE's market value can be influenced by many factors that don't directly affect Evotec SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evotec SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evotec SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evotec SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.